Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2005



The knowledge on the ‘3rd type hematogones’ could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia
Authors: O. BABUSIKOVA, T. ZELEZNIKOVA, A. MLCAKOVA, J. KUSENDA, L. STEVULOVA
Neoplasma Vol.52, p.502-509, 2005
[View Abstract]


Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study
Authors: J., MARDIAK ; T., SALEK ; Z., SYCOVA-MILA ; J., OBERTOVA ; Z., HLAVATA ; M., MEGO ; M., RECKOVA ; I., KOZA ;
Neoplasma Vol.52, p.497-501, 2005
[View Abstract]



The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line
Authors: A., GRZANKA ; A., ZURYN ; J., STYCZYNSKI ; A.A., GRZANKA ; H., WISNIEWSKA ;
Neoplasma Vol.52, p.489-493, 2005
[View Abstract]


Predictors of local failure in early laryngeal cancer
Authors: R., LOHYNSKA ; A., SLAVICEK ; A., BAHANAN ; P., NOVAKOVA ;
Neoplasma Vol.52, p.483-488, 2005
[View Abstract]



Comparative assessment of the cytotoxic effects of carboxylato-bridged dinuclear platinum (II) complexes against human tumor cell lines
Authors: G. MOMEKOV, A. BAKALOVA, S. KONSTANTINOV, D. TODOROV, M. KARAIVANOVA
Neoplasma Vol.52, p.469-475, 2005
[View Abstract]


Expression of the P65 gene in gastric cancer and in tissues with or without Helicobacter pylori infection
Authors: E., BALCERCZAK ; T., JANKOWSKI ; A., BECHT ; M., BALCERCZAK ; R., JANIUK ; D., JESIONEK-KUPNICKA ; J., SZTOMPKA ; M., MIROWSKI ;
Neoplasma Vol.52, p.464-468, 2005
[View Abstract]


High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
Authors: J., STERBA ; D., VALIK ; V., BAJCIOVA ; V., KADLECOVA ; V., GREGOROVA ; D., MENDELOVA ;
Neoplasma Vol.52, p.456-463, 2005
[View Abstract]


Structure-activity relationship of trans-resveratrol and its analogues
Authors: Z. OVESNA, K. HORVATHOVA-KOZICS
Neoplasma Vol.52, p.450-455, 2005
[View Abstract]


Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment
Authors: D., KOSTANOVA-POLIAKOVA ; Ľ., SABOVA ;
Neoplasma Vol.52, p.441-449, 2005
[View Abstract]


Cancer stem cells
Authors: A., SOLTYSOVA ; V., ALTANEROVA ; C., ALTANER ;
Neoplasma Vol.52, p.435-440, 2005
[View Abstract]


The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia
Authors: J.M., HORACEK ; R., PUDIL ; M., TICHY ; L., JEBAVY ; A., STRASOVA ; R., PRAUS ; P., ZAK ; J., MALY ;
Neoplasma Vol.52, p.430-434, 2005
[View Abstract]


Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer
Authors: C.T.F., OSHIMA ; K., IRIYA ; N.M., FORONES ;
Neoplasma Vol.52, p.420-424, 2005
[View Abstract]


Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization
Authors: J., BEDRNICEK ; A., VICHA ; M., JAROSOVA ; M., HOLZEROVA ; J., CINATL, JR. ; M., MICHAELIS ; J., CINATL ; T., ECKSCHLAGER ;
Neoplasma Vol.52, p.415-419, 2005
[View Abstract]


Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy
Authors: M., DOUBEK ; I., PALASEK ; Y., BRYCHTOVA ; I., BUCHTOVA ; J., MAYER ;
Neoplasma Vol.52, p.411-414, 2005
[View Abstract]


Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression
Authors: C., JUNGHANSS ; M., WAAK ; A., KNOPP ; H.D., KLEINE ; G., KUNDT ; M., LEITHAUSER ; I., HILGENDORF ; D., WOLFF ; J., CASPER ; M., FREUND ;
Neoplasma Vol.52, p.402-410, 2005
[View Abstract]






Display #  
Results 1 - 20 of 84

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.